Treadwell Therapeutics Revenue and Competitors



Total Funding



Estimated Revenue & Valuation

  • Treadwell Therapeutics's estimated annual revenue is currently $4.3M per year.(i)
  • Treadwell Therapeutics's estimated revenue per employee is $77,500
  • Treadwell Therapeutics's total funding is $118M.

Employee Data

  • Treadwell Therapeutics has 56 Employees.(i)
  • Treadwell Therapeutics grew their employee count by -8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Treadwell Therapeutics is a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers by targeting critical tumor-specific vulnerabilities including aneuploidy and immunogenicity. The Company’s robust, internally developed pipeline includes novel small molecule drugs in single agent and combination studies. Lead candidate, CFI-400945, is a PLK4 inhibitor in multiple Phase 1 and Phase 2 trials including for TNBC, prostate cancer and AML. Additional product candidates include CFI-402257, a clinical stage TTK inhibitor, as well as CFI-402411, a preclinical HPK1 inhibitor (IND filing 1H20), which is positioned to be the first clinical stage small molecule modulator of a unique node of T cell activation and has a mechanism distinct from PD1/PDL1. Interested in joining Treadwell Therapeutics? Visit our Career page:



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Treadwell Therapeutics News

2022-04-19 - Treadwell Therapeutics Announces Fast Track Designation ...

Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-400945 for the Treatment of Acute Myeloid Leukemia...

2022-04-13 - Treadwell Therapeutics Announces the Appointment of JD ...

NEW YORK and HONG KONG, April 19, 2022 /PRNewswire/ -- Treadwell Therapeutics ("Treadwell"), a clinical-stage biotechnology company...

2022-03-30 - Treadwell Therapeutics and University Health Network Sign ...

Treadwell Therapeutics is a science driven, clinical-stage, multi-modality biotechnology company developing first-in-class and best-in-class...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding